Global AI Drug Development Platform Market Growth (Status and Outlook) 2023-2029

Global AI Drug Development Platform Market Growth (Status and Outlook) 2023-2029

The global AI Drug Development Platform market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for AI Drug Development Platform is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for AI Drug Development Platform is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for AI Drug Development Platform is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key AI Drug Development Platform players cover Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm and Genesis Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “AI Drug Development Platform Industry Forecast” looks at past sales and reviews total world AI Drug Development Platform sales in 2022, providing a comprehensive analysis by region and market sector of projected AI Drug Development Platform sales for 2023 through 2029. With AI Drug Development Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Drug Development Platform industry.

This Insight Report provides a comprehensive analysis of the global AI Drug Development Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI Drug Development Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Drug Development Platform market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Drug Development Platform and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Drug Development Platform.

This report presents a comprehensive overview, market shares, and growth opportunities of AI Drug Development Platform market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Software Provider Mode
CRO Service Mode
Self-Development Pipeline Mode

Segmentation by application
SMEs
Large Enterprises

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba

Please note: The report will take approximately 2 business days to prepare and deliver.